カテゴリ： GlobalData, アメリカ, 企業調査

NeuroMetrix Inc (NURO)-医療機器分野：企業M&A・提携分析

◆英語タイトル：NeuroMetrix Inc (NURO) - Medical Equipment - Deals and Alliances Profile
◆商品コード：DATA8011198
◆発行会社（調査会社）：GlobalData
◆発行日：2017年12月22日
◆ページ数：62
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single UserUSD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
NeuroMetrix Inc (NeuroMetrix) is a medical device company that develops wearable medical technology and point of care test to manage chronic pain, nerve diseases, and sleep disorders. The company’s products include quell wearable pain relief device, SENSUS pain therapy device, NC-stat DPNCheck and advance NCS system. Its SENSUS pain therapy and NC-stat DPNCheck are used for the treatment of diabetic peripheral neuropathy. NeuroMetrix has expertise in basic and clinical neurophysiology, biomedical engineering and instrumentation, and information technology. The company caters to clinics, hospitals, managed care organizations, retail health businesses, and durable medical equipment suppliers. It markets its products through distributors in the US, Europe, Asia, and the Middle East. NeuroMetrix is headquartered in Waltham, Massachusetts, the US.

NeuroMetrix Inc (NURO) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
NeuroMetrix Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
NeuroMetrix Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
NeuroMetrix Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
NeuroMetrix Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
NeuroMetrix Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
NeuroMetrix Inc, Medical Equipment, Deal Details 11
Partnerships 11
NeuroMetrix Enters into Agreement with Fukuda Denshi 11
NeuroMetrix Enters into Agreement with Synovation Medical 12
NeuroMetrix Enters into Agreement with Scripps Translational Science Institute 13
NeuroMetrix Enters Into Distribution Agreement With DJO Global For Sensus Pain Management System 14
NeuroMetrix Enters Into Distribution Agreement With Omron Healthcare For NC-stat DPNCheck 15
NeuroMetrix Enters Into Distribution Agreement With Omron Healthcare For NC-stat DPNCheck 16
NeuroMetrix Enters Into Distribution Agreement With Handok Pharma For NC-stat DPNCheck 17
Equity Offering 18
NeuroMetrix Raises USD3.5 Million in Private Placement of First Tranche of Series F Preferred Stock 18
NeuroMetrix Plans to Raise Funds through Public Offering of Shares 20
NeuroMetrix Raises USD4 Million in Private Placement of Series E Preferred Stock and Warrants 21
NeuroMetrix Prices Public Offering of Shares for USD26.5 Million 23
NeuroMetrix Raises USD21.3 Million in Private Placement of Shares and Warrants 25
NeuroMetrix Raises USD13.8 Million in Private Placement of Shares and Warrants 26
NeuroMetrix Raises USD14.7 Million in Public Offering of Units 28
NeuroMetrix Raises USD8 Million in Private Placement of Securities 30
NeuroMetrix Completes Private Placement Of Preferred Shares For US$5 Million 31
NeuroMetrix Completes Public Offering Of Units For US$8.5 Million 32
NeuroMetrix Inc – Key Competitors 33
NeuroMetrix Inc – Key Employees 34
NeuroMetrix Inc – Locations And Subsidiaries 35
Head Office 35
Other Locations & Subsidiaries 35
Joint Venture 35
Recent Developments 36
Financial Announcements 36
Oct 19, 2017: NeuroMetrix Reports Q3 2017 Financial Results 36
Jul 20, 2017: NeuroMetrix Reports Q2 2017 Financial Results 37
Apr 20, 2017: NeuroMetrix Reports Q1 2017 Financial Results 38
Jan 26, 2017: NeuroMetrix Reports Q4 and Full Year 2016 Financial Results 39
Jan 10, 2017: NeuroMetrix Reports Strong Quell Demand in Q4 2016 40
Oct 20, 2016: NeuroMetrix Reports Q3 2016 Financial Results 41
Jul 21, 2016: NeuroMetrix Reports Q2 2016 Financial Results and Highlights 42
Apr 21, 2016: NeuroMetrix Reports Q1 2016 Financial Results and Highlights 43
Jan 28, 2016: NeuroMetrix Reports Q4 2015 Financial Results and Highlights 44
Jan 11, 2016: NeuroMetrix Reports Preliminary Financial Highlights for 2015 45
Corporate Communications 46
Jul 06, 2017: NeuroMetrix Reports Promotion of Michael MacDonald to Senior Vice President and General Manager of Diagnostics 46
Nov 08, 2016: NeuroMetrix Announces Promotion of Frank McGillin to Chief Commercial Officer 47
Product News 48
Aug 03, 2016: NeuroMetrix To Present Quell Wearable Pain Technology at National Association of Chain Drug Stores Total Store Expo 48
May 26, 2016: NeuroMetrix Reports the Launch of the Quell Health Cloud for Android 49
03/17/2016: NeuroMetrix Announces Availability of Quell at Target 50
03/16/2016: Quell Named Best Wearable Technology in 2016 SXSW Interactive Innovation Awards 51
03/10/2016: NeuroMetrix Showcases Quell Wearable Pain Relief Technology at the 2016 SXSW Show 52
03/02/2016: NeuroMetrix Announces Availability of the Newest Version of Quell Wearable Pain Relief Technology 53
02/16/2016: NeuroMetrix Showcases Quell Technology at American Physical Therapy Association Meeting 54
02/10/2016: NeuroMetrix Showcases Quell Technology at the American Academy of Pain Medicine Annual Meeting 55
02/04/2016: NeuroMetrix to Present at Source Capital Group’s 2016 Disruptive Growth & Healthcare Conference 56
02/04/2016: Quell Wearable Pain Relief Technology Selected as a Finalist in SXSW Interactive Innovation Awards 57
01/28/2016: NeuroMetrix Showcases Quell Technology at the North Carolina Foot & Ankle Society’s Winter Scientific Seminar 58
01/21/2016: NeuroMetrix Reports Regulatory Approval for DPNCheck in China 59
01/21/2016: NeuroMetrix Showcases Quell Technology at the New York Podiatric Clinical Conference 60
Product Approvals 61
Jan 21, 2016: NeuroMetrix Reports Regulatory Approval for DPNCheck in China 61
Appendix 62
Methodology 62
About GlobalData 62
Contact Us 62
Disclaimer 62

List of Tables
NeuroMetrix Inc, Medical Equipment, Key Facts, 2016 2
NeuroMetrix Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
NeuroMetrix Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
NeuroMetrix Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
NeuroMetrix Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
NeuroMetrix Inc, Deals By Market, 2011 to YTD 2017 9
NeuroMetrix Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
NeuroMetrix Enters into Agreement with Fukuda Denshi 11
NeuroMetrix Enters into Agreement with Synovation Medical 12
NeuroMetrix Enters into Agreement with Scripps Translational Science Institute 13
NeuroMetrix Enters Into Distribution Agreement With DJO Global For Sensus Pain Management System 14
NeuroMetrix Enters Into Distribution Agreement With Omron Healthcare For NC-stat DPNCheck 15
NeuroMetrix Enters Into Distribution Agreement With Omron Healthcare For NC-stat DPNCheck 16
NeuroMetrix Enters Into Distribution Agreement With Handok Pharma For NC-stat DPNCheck 17
NeuroMetrix Raises USD3.5 Million in Private Placement of First Tranche of Series F Preferred Stock 18
NeuroMetrix Plans to Raise Funds through Public Offering of Shares 20
NeuroMetrix Raises USD4 Million in Private Placement of Series E Preferred Stock and Warrants 21
NeuroMetrix Prices Public Offering of Shares for USD26.5 Million 23
NeuroMetrix Raises USD21.3 Million in Private Placement of Shares and Warrants 25
NeuroMetrix Raises USD13.8 Million in Private Placement of Shares and Warrants 26
NeuroMetrix Raises USD14.7 Million in Public Offering of Units 28
NeuroMetrix Raises USD8 Million in Private Placement of Securities 30
NeuroMetrix Completes Private Placement Of Preferred Shares For US$5 Million 31
NeuroMetrix Completes Public Offering Of Units For US$8.5 Million 32
NeuroMetrix Inc, Key Competitors 33
NeuroMetrix Inc, Key Employees 34
NeuroMetrix Inc, Joint Venture 35

★海外企業調査レポート[NeuroMetrix Inc (NURO)-医療機器分野：企業M&A・提携分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Sensus Healthcare Inc (SRTS)：製品パイプライン分析
    Summary Sensus Healthcare Inc (Sensus), previously Sensus Healthcare LLC, designs, manufactures, and markets proprietary medical devices for the treatment of various types of cancers and skin diseases. The company offers superficial radiation therapy (SRT) technology based non-surgical treatment opt …
  • Turkiye Garanti Bankasi AS：戦略・SWOT・企業財務分析
    Turkiye Garanti Bankasi AS - Strategy, SWOT and Corporate Finance Report Summary Turkiye Garanti Bankasi AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • China National Pharmaceutical Group Corp-製薬・医療分野：企業M&A・提携分析
    Summary China National Pharmaceutical Group Corp (Sinopharm) is a provider of medical and healthcare services. Its core businesses include the distribution, retailing, research and manufacture of healthcare related products. Its product portfolio includes EPI vaccines; biopharmaceutical products; an …
  • Celldex Therapeutics, Inc.：企業のM&A・事業提携・投資動向
    Celldex Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Celldex Therapeutics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Clayton Homes Inc：企業の戦略・SWOT・財務情報
    Clayton Homes Inc - Strategy, SWOT and Corporate Finance Report Summary Clayton Homes Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • HSBC Trinkaus & Burkhardt AG (TUB)：企業の財務・戦略的SWOT分析
    HSBC Trinkaus & Burkhardt AG (TUB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Biosynex SA (ALBIO)：医療機器：M&Aディール及び事業提携情報
    Summary Biosynex SA (Biosynex), formerly All Diag Sarl is an in-vitro diagnostic company that manufactures, research, and develops rapid diagnostic tests. The company offers rapid diagnostic kits for diagnostic applications; and designing, self-measurement, and distributing thermometers. It offers t …
  • American Greetings Corporation (AM)：企業の戦略的SWOT分析
    American Greetings Corporation (AM) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Costco Wholesale Corporation：企業の戦略・SWOT・財務分析
    Costco Wholesale Corporation - Strategy, SWOT and Corporate Finance Report Summary Costco Wholesale Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • SSA Marine, Inc.：企業の戦略・SWOT・財務分析
    SSA Marine, Inc. - Strategy, SWOT and Corporate Finance Report Summary SSA Marine, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Cameron International Corporation：石油・ガス：M&Aディール及び事業提携情報
    Summary Cameron International Corporation (Cameron), a subsidiary of Schlumberger Limited specializes in engineering, designing, and manufacturing flow and pressure control technologies for oil and gas industry. The company offers drilling systems, dryaccess deepwater production systems, safety syst …
  • Tesaro Inc (TSRO)-製薬・医療分野：企業M&A・提携分析
    Summary Tesaro Inc (Tesaro) is an oncology-focused biopharmaceutical company that focuses on developing in-licensed, oncology-related product candidates, comprising rolapitant, niraparib, and the product candidates under its immuno-oncology platform. VARUBI, the company’s first commercial product is …
  • Sinopec Oilfield Service Corp (600871)：企業の財務・戦略的SWOT分析
    Sinopec Oilfield Service Corp (600871) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Lagardere SCA：企業のM&A・事業提携・投資動向
    Lagardere SCA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Lagardere SCA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Visterra Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Visterra Inc (Visterra), formerly Parasol Therapeutics Inc is a clinical-stage biopharmaceutical company that develops antibody therapies for the treatment of infectious diseases. The company develops precision antibody-based biological medicines for infectious and non-infectious diseases. I …
  • Lallemand Inc：企業の戦略・SWOT・財務情報
    Lallemand Inc - Strategy, SWOT and Corporate Finance Report Summary Lallemand Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Saskatchewan Power Corporation：企業の発電所・SWOT分析2018
    Saskatchewan Power Corporation - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on ke …
  • Indianapolis Power & Light Co：企業の戦略的SWOT分析
    Indianapolis Power & Light Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Intellia Therapeutics Inc (NTLA)：企業の財務・戦略的SWOT分析
    Summary Intellia Therapeutics Inc (Intellia Therapeutics) is a genome editing company that develops proprietary curative therapeutics using CRISPR/Cas9 technology. The company develops in vivo programs for the treatment of liver diseases such as alpha-1 antitrypsin deficiency, hepatitis B infection, …
  • Alcon Inc (ALC)：企業の財務・戦略的SWOT分析
    Alcon Inc (ALC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆